Australian patients with severe COVID‐19 pneumonia treated with tocilizumab have had favourable clinical outcomes, a small case series shows. The positive findings make a case for tocilizumab be included in randomised controlled trials of treatment for patients with severe COVID‐19 pneumonia, and for it to be considered for compassionate use pending the results of these ...
Australian cases show favourable outcomes for tocilizumab use early in COVID-19 disease
By Mardi Chapman
26 Aug 2020